dual gip and glp-1 receptor agonist GIP/GLP-1 agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

Here, we found that targeting CD38 in 5xFAD mice contributed to restoration of the metabolic fitness that is lost in AD, and protection against cognitive decline

[DOI] [PMC free article] [PubMed] [Google Scholar] 140.Brini M., Cal T., Ottolini D., Carafoli E

NAPQI crosses the placenta, depletes her baby's brain glutathione, and damages developing neurons

GLP-1 side effects doctors want you to know While GLP-1s can be game-changers when it comes to treating insulin resistance, regulating blood sugar and helping people achieve significant weight loss, they're not without risk of side effects

Think of it as acclimation, not optimization